Chronic Kidney Disease Trial, Recruiting NCT06324045 Sponsor: Hamad Medical Corporation Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT06324045
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People diagnosed with end-stage kidney disease (when the kidneys have nearly or completely stopped working) who are currently receiving dialysis treatment through a machine that filters the blood.
  • People with advanced kidney disease who are being monitored at a specialist clinic before dialysis becomes necessary.
  • People who have been receiving care at one of the kidney treatment centers in Qatar for at least two months.
  • People who are able to communicate in Arabic and/or English.

Who may not be able to join:

  • People who have an unstable or active psychiatric (mental health) condition.
  • People who display uncontrolled behaviors or are repeatedly trying to leave the care setting out of confusion, frustration, or anger.
  • People who are critically ill, pregnant, under 18 years of age, living with a serious mental illness, living with dementia, or currently unconscious.
  • People whose doctors estimate they have less than six months to live.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hasan Al-Malki, MD, Head of Nephrology Division, Hamad Medical Corporation

Phone: +97444394888

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hamad Medical Corporation
Registry
ClinicalTrials.gov
Start date
19 February 2024
Est. completion
1 December 2025

Where this trial is recruiting

Qatar

Primary endpoints

Percentage of participants with at least one Potentially inappropriate medications (PIMs); Number of Potentially inappropriate medications (PIMs)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov